HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024

Rhea-AI Summary

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) will report fourth quarter and full year 2023 financial results on February 22, 2024. A conference call and live webcast will be hosted to discuss the results. The call details and webcast link are available on the investor page of the company's website.

PLYMOUTH MEETING, Pa., Feb. 8, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report fourth quarter and full year 2023 financial results on Thursday, February 22, 2024, before the open of the U.S. financial markets. Harmony will host a conference call and live webcast on February 22, 2024, at 8:30 a.m. ET to discuss the results.

To participate in the call, please dial (800) 579-2543 (domestic) or +1 (785) 424-1789 (international), and reference passcode HRMYQ423. It is recommended that you dial in at least 10 minutes prior to the call.

The live and replay webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com

Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-22-2024-302056777.html

SOURCE Harmony Biosciences

FAQ

When will Harmony Biosciences report its Q4 and full year 2023 financial results?

Harmony Biosciences will report its Q4 and full year 2023 financial results on February 22, 2024.

What is the ticker symbol for Harmony Biosciences Holdings, Inc.?

The ticker symbol for Harmony Biosciences Holdings, Inc. is HRMY.

Where can I find the details for the conference call and live webcast?

The details for the conference call and live webcast can be found on the investor page of the company's website at https://ir.harmonybiosciences.com/.

How can I participate in the conference call?

To participate in the call, please dial (800) 579-2543 (domestic) or +1 (785) 424-1789 (international), and reference passcode HRMYQ423.

What time will the conference call and live webcast take place?

The conference call and live webcast will take place on February 22, 2024, at 8:30 a.m. ET.